Cale N Basaraba1, Carolyn L Westhoff2, Malcolm C Pike3, Renu Nandakumar4, Serge Cremers5. 1. Department of Obstetrics and Gynecology and Epidemiology, Columbia University Medical Center, New York, NY, USA. 2. Department of Obstetrics and Gynecology and Epidemiology, Columbia University Medical Center, New York, NY, USA. Electronic address: clw3@columbia.edu. 3. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA. 4. Irving Institute for Clinical and Translational Research, Columbia University Medical Center, New York, NY, USA. 5. Irving Institute for Clinical and Translational Research, Columbia University Medical Center, New York, NY, USA; Departments of Pathology and Cell Biology, and Medicine, Columbia University Medical Center, New York, NY, USA.
Abstract
OBJECTIVE: The gold standard for measuring oral contraceptive (OC) pharmacokinetics is the 24-h steady-state area under the curve (AUC). We conducted this study to assess whether limited sampling at steady state or measurements following use of one or two OCs could provide an adequate proxy in epidemiological studies for the progestin 24-h steady-state AUC of a particular OC. STUDY DESIGN: We conducted a 13-sample, 24-h pharmacokinetic study on both day 1 and day 21 of the first cycle of a monophasic OC containing 30-mcg ethinyl estradiol and 150-mcg levonorgestrel (LNG) in 17 normal-weight healthy White women and a single-dose 9-sample study of the same OC after a 1-month washout. We compared the 13-sample steady-state results with several steady-state and single-dose results calculated using parsimonious sampling schemes. RESULTS: The 13-sample steady-state 24-h LNG AUC was highly correlated with the steady-state 24-h trough value [r=0.95; 95% confidence interval (0.85, 0.98)] and with the steady-state 6-, 8-, 12- and 16-h values (0.92≤r≤0.95). The trough values after one or two doses were moderately correlated with the steady-state 24-h AUC value [r=0.70; 95% CI (0.27, 0.90) and 0.77; 95% CI (0.40, 0.92), respectively]. CONCLUSIONS: Single time-point concentrations at steady state and after administration of one or two OCs gave highly to moderately correlated estimates of steady-state LNG AUC. Using such measures could facilitate prospective pharmaco-epidemiologic studies of the OC and its side effects. IMPLICATIONS: A single time-point LNG concentration at steady state is an excellent proxy for complete and resource-intensive steady-state AUC measurement. The trough level after two single doses is a fair proxy for steady-state AUC. These results provide practical tools to facilitate large studies to investigate the relationship between systemic LNG exposure and side effects in a real-life setting.
OBJECTIVE: The gold standard for measuring oral contraceptive (OC) pharmacokinetics is the 24-h steady-state area under the curve (AUC). We conducted this study to assess whether limited sampling at steady state or measurements following use of one or two OCs could provide an adequate proxy in epidemiological studies for the progestin 24-h steady-state AUC of a particular OC. STUDY DESIGN: We conducted a 13-sample, 24-h pharmacokinetic study on both day 1 and day 21 of the first cycle of a monophasic OC containing 30-mcg ethinyl estradiol and 150-mcg levonorgestrel (LNG) in 17 normal-weight healthy White women and a single-dose 9-sample study of the same OC after a 1-month washout. We compared the 13-sample steady-state results with several steady-state and single-dose results calculated using parsimonious sampling schemes. RESULTS: The 13-sample steady-state 24-h LNG AUC was highly correlated with the steady-state 24-h trough value [r=0.95; 95% confidence interval (0.85, 0.98)] and with the steady-state 6-, 8-, 12- and 16-h values (0.92≤r≤0.95). The trough values after one or two doses were moderately correlated with the steady-state 24-h AUC value [r=0.70; 95% CI (0.27, 0.90) and 0.77; 95% CI (0.40, 0.92), respectively]. CONCLUSIONS: Single time-point concentrations at steady state and after administration of one or two OCs gave highly to moderately correlated estimates of steady-state LNG AUC. Using such measures could facilitate prospective pharmaco-epidemiologic studies of the OC and its side effects. IMPLICATIONS: A single time-point LNG concentration at steady state is an excellent proxy for complete and resource-intensive steady-state AUC measurement. The trough level after two single doses is a fair proxy for steady-state AUC. These results provide practical tools to facilitate large studies to investigate the relationship between systemic LNG exposure and side effects in a real-life setting.
Authors: Carolyn L Westhoff; Anupama H Torgal; Elizabeth R Mayeda; Malcolm C Pike; Frank Z Stanczyk Journal: Contraception Date: 2010-02-20 Impact factor: 3.375
Authors: Eduard M Scholten; Serge C L M Cremers; Rik C Schoemaker; Ajda T Rowshani; Erik J van Kan; Jan den Hartigh; Leendert C Paul; Johan W de Fijter Journal: Kidney Int Date: 2005-06 Impact factor: 10.612
Authors: Marcos de Bastos; Bernardine H Stegeman; Frits R Rosendaal; Astrid Van Hylckama Vlieg; Frans M Helmerhorst; Theo Stijnen; Olaf M Dekkers Journal: Cochrane Database Syst Rev Date: 2014-03-03
Authors: Carolyn L Westhoff; Hua Guo; Zhong Wang; Hanina Hibshoosh; Margaret Polaneczky; Malcolm C Pike; Richard Ha Journal: Breast Cancer Res Treat Date: 2022-01-11 Impact factor: 4.624
Authors: Dandan Luo; Carolyn L Westhoff; Alison B Edelman; Melissa Natavio; Frank Z Stanczyk; William J Jusko Journal: Contraception Date: 2019-01-23 Impact factor: 3.375
Authors: Charlotte Ginstman; Helena Kopp Kallner; Johanna Fagerberg-Silwer; Björn Carlsson; Andreas Ärlemalm; Ylva Böttiger; Jan Brynhildsen Journal: Obes Surg Date: 2020-06 Impact factor: 4.129